A particular issue within widening participation (WP) outreach is the dearth of studies able to make robust causal claims. We posit here that ethical issues related to Randomised Controlled Trial (RCT) implementation are problematic and need to be addressed. We do so here in the adoption of a novel pedagogy and encourage other actors within this space to adopt greater risk and innovation across all aspects of practice.
No takes yet. Share an insight, caveat, or question.
Hoskin-Campion et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: